Supernus Pharmaceuticals, Inc. (SUPN) Earnings
NASDAQ·Healthcare·Drug Manufacturers - Specialty & Generic
$48.70
-1.54%
Mkt Cap $2.87B
Next Earnings
In 6 daysTue, May 5, 2026
EPS Estimate
$0.26
2 analysts
Revenue Estimate
$193.14M
Last quarter: beat by +228.57% on EPS, +8.41% on revenue.
EPS — Estimate vs Actual
Mkt Cap
$2.87B
P/E
—
Fwd P/E
25.99
P/S
3.99
Rev TTM
—
EPS TTM
-$0.68